Gadolinium-based contrast agents (GBCAs) used in MRI and angiography contain a chelated form of the toxic heavy metal that was assumed to clear the body shortly after intravenous administration. [1] ...

A new magnetic resonance imaging (MRI) contrast agent being tested by researchers at Case Western Reserve University not only pinpoints breast cancers at early stages but differentiates between ...

An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...

Contrast agents could provide an efficient means for physicians to detect infections through imaging, rather than unnecessarily prescribing antibiotics, according to a Technology Review report. Two ...

Nanomedicine. 2015;10(2):321-341. Delivery: "Go where we want." The contrast agent must be able to be delivered in vivo and transported to the site of interest. Nontoxic: "Do no harm along the way." ...

In a possible first, researchers at Stanford (Calif.) Medicine found a non-invasive imaging method to visualize senescent cells. “As we age, we accumulate senescent cells. These are like ‘zombie cells ...

CORVALLIS, Ore. (KTVZ) -– Scientists at Oregon State University have filed a patent on a design for a new magnetic resonance imaging contrast agent with the potential to outperform current agents ...

Medically reviewed by Rony Kampalath, MD Key Takeaways An MRI with contrast uses a special dye to make blood vessels, organs, and tissues stand out more clearly.The dye used in MRI with contrast ...

Prefer Newsweek on Google to see more of our trusted coverage when you search. A new study has found why MRI scans may leave harmful metals behind in a person's body. The University of New Mexico (UNM ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--GE Healthcare’s innovative shatterproof polymer +PLUSPAK Pharmacy Bulk Package has been approved by the US FDA for use with its macrocyclic gadolinium-based MRI ...